HC Wainwright Issues Optimistic Estimate for DNLI Earnings
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Analysts at HC Wainwright raised their Q2 2025 earnings estimates for Denali Therapeutics in a note issued to investors on Wednesday, May 7th. HC Wainwright analyst A. Fein now forecasts that the company will earn ($0.68) per share for the quarter, up from their prior forecast of […]
